Biotech Calendar: Key Dates for December
A calendar of important, potentially stock-moving biotech events for December.
09:56AM 11/30/09
Seagate Chairman Buys $1.2M Worth
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:15AM 08/27/09
Insider Sells $2M of Dow Chemical
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
11:33AM 08/11/09
Synta and GSK Part Ways Over Cancer Drug
The venture between Synta and GSK ends, while GSK cements another deal with Dr. Reddy's.
04:21PM 06/15/09
Glaxo Pulls Out Of Synta Cancer Drug Collaboration
GlaxoSmithKline ends collaboration with Synta Pharmaceuticals on developing cancer drug
07:39AM 06/15/09
Synta Says Cancer Drug Did Not Meet Study Goal
Synta says elesclomol missed survival goal in trial that was stopped due to patient deaths
04:34PM 06/01/09
Biotech Data Preview: ASCO's Top Stories
Investors are watching for key data from a handful of drug trials at this year's ASCO conference.
12:06PM 05/12/09
No Great Expectations for Big Biotech Event (Biotech Select $)
With a dearth of important clinical data, this upcoming annual meeting for cancer drug research will likely disappoint investors.
08:31AM 05/06/09
Synta to Cut 90 Jobs After Skin Cancer Trial Halted
The trial's suspension could put in jeopard Synta's $1 billion deal with GlaxoSmithKline, according to a report.
12:44PM 03/13/09
Synta Skin Cancer Drug Trial Halted
Safety problems derail Synta skin cancer trial.
05:13PM 02/26/09
Health Winners and Losers: Lilly's New Big Mac
Shares of Eli Lilly, which named McDonald's COO to its board, were slipping Wednesday afternoon.
04:42PM 02/18/09
Four Must-See Charts of the Day
Cut through the market clutter with charts. Here are four to watch.
01:29PM 02/03/09
Synta Seeing Unusual Options Activity
Pharmaceutical stocks have been particularly active recently as the industry undergoes consolidation.
07:34AM 02/02/09
BIO CEO '09: Small Biotech's Time to Shine
This year's BIO CEO confab gives investors a chance to browse biotech companies trading at historically low valuations.
09:54AM 01/30/09
Highlights From the J.P. Morgan Health Confab
Adam Feuerstein gives the lowdown on this year's conference in San Francisco.
05:02PM 01/16/09



Connect with TheStreet